UPDATED Sep 30, 2025
Discover U.S. Pharmaceuticals & Biotech Growth Stocks that are on the NYSE and NASDAQ. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
SNDL | US$2.68 | 7.2% | 34.7% | US$705.1m | US$4.76 | PS1x | E162.8% | n/a | ||
SBFM | US$1.49 | -5.7% | -51.6% | US$6.6m | US$7.00 | PB0.3x | E147.7% | n/a | ||
TLRY | US$1.73 | 39.5% | 3.0% | US$2.1b | n/a | PS2.4x | E141.3% | n/a | ||
MIRA | US$1.36 | 4.6% | 14.3% | US$25.4m | US$17.75 | PB45.5x | E112.8% | n/a | ||
EVOK | US$4.97 | -3.5% | 2.1% | US$10.1m | US$18.00 | PB2.4x | E110.9% | n/a | ||
ORGO | US$4.22 | -11.3% | 49.6% | US$540.4m | US$8.00 | PS1.2x | E109.0% | n/a | ||
AZTA | US$28.72 | -4.9% | -39.5% | US$1.3b | US$33.00 | PS2x | E102.2% | 0% | ||
HBIO | US$0.44 | -4.2% | -82.7% | US$19.6m | US$2.00 | PB1.2x | E98.7% | n/a | ||
PLX | US$2.22 | 13.3% | 111.4% | US$172.2m | US$14.00 | PE28.2x | E88.4% | n/a | ||
EXAS | US$54.71 | 4.4% | -19.6% | US$10.1b | US$64.92 | PS3.5x | E84.8% | n/a | ||
AMRN | US$16.38 | 6.6% | 32.1% | US$332.6m | US$11.00 | PS1.5x | E83.2% | n/a | ||
AMRX | US$10.01 | 1.7% | 15.1% | US$3.1b | US$12.50 | PE931.5x | E80.6% | 0% | ||
CAI | US$30.25 | -5.8% | n/a | US$8.4b | US$39.38 | PS15.9x | E80.2% | n/a | ||
VTRS | US$9.90 | 3.1% | -13.8% | US$11.2b | US$11.43 | PB0.7x | E77.9% | 4.8% | ||
MYGN | US$7.23 | -6.1% | -73.3% | US$673.2m | US$7.50 | PB1.7x | E77.6% | n/a | ||
ALDX | US$5.22 | 2.2% | -1.3% | US$312.8m | US$9.50 | PB5.7x | E74.8% | n/a | ||
ITRM | US$0.67 | -5.6% | -36.8% | US$30.6m | US$7.00 | PE-1.2x | E74.8% | n/a | ||
MDXH | US$4.65 | 3.3% | 129.1% | US$230.2m | US$6.04 | PS2.3x | E74.6% | n/a | ||
BRTX | US$1.45 | 0% | -8.2% | US$11.6m | US$13.00 | PS19.1x | E74.2% | n/a | ||
OMER | US$4.10 | -4.2% | 7.3% | US$284.5m | US$22.50 | PE-2x | E73.5% | n/a | ||
OCGN | US$1.63 | -1.8% | 71.6% | US$452.8m | US$8.20 | PS107.1x | E73.5% | n/a | ||
CLGN | US$2.69 | 5.5% | -45.3% | US$39.3m | US$11.56 | PS14.2x | E72.6% | n/a | ||
APRE | US$1.48 | 2.4% | -43.3% | US$8.8m | US$10.50 | PS10.2x | E72.0% | n/a | ||
CLNN | US$6.03 | -1.6% | 31.0% | US$60.3m | US$30.43 | PS212.1x | E72.0% | n/a |